Epidemiologic characteristic of hepatitis B in the Splitsko-Dalmatinska county;Epidemiološke karakteristike hepatitisa B u Splitsko-Dalmatinskoj županiji

Lijecnicki Vjesnik

Volumn 128, Issue 3-4, 2006, Pages 65-71

  Mulić, Rosanda ^a   Uglešić, Lovro ^a   Klišmanić, Zorana ^b   Ropac, Darko ^b   Smoljanović, Mladen ^b   Mratinović Mikulandra, Jela ^c   Aleraj, Borislav ^b   Lučev, Oskar ^b  

^a UNIVERSITY OF SPLIT   (Croatia)

^b Zavod za Javno Zdravstvo Splitsko Dalmatinske Županije ^*

^c UNIVERSITY HOSPITAL SPLIT   (Croatia)

Author keywords

Croatia epidemiology; Hepatitis B epidemiology

Indexed keywords

ARTICLE; CROATIA; DRUG USE; FEMALE; HEPATITIS B VIRUS; HUMAN; MALE; MORBIDITY; MORTALITY; SEXUAL BEHAVIOR; VIRUS INFECTION; ADOLESCENT; ADULT; CHILD; HEPATITIS B; MIDDLE AGED; PRESCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CROATIA; FEMALE; HEPATITIS B; HUMANS; MALE; MIDDLE AGED;

EID: 33646807838     PISSN: 00243477     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Palmović D. Virusni hepatitis. Zagreb: Školska knjiga; 2004, str. 29-54.
2. Hepatitis B vaccines. Weekly epidemiological record 2004;79:255-63.
3. World Health Organization. Hepatitis B vaccine. Immunization, Vacines and Biologicals. www.who.int/vaccines.documents.
4. Milas J, Ropac D, Mulic R i sur. Hepatitis B in the family. Eur J Epidemiol 2000;16:203-8.
5. Hadžić N. Akutni virusni hepatitis. U: Vrhovac B i sur, ur. Interna medicina. Zagreb: Naprijed; 1997, str. 1025-8.
6. Hadžić N. Kronični hepatitis. U: Vrhovac B i sur, ur. Interna medicina. Zagreb: Naprijed; 1997, str. 1033-6.
7. Robinson WS. Hepatitis B Virus and Hepatitis D Virus. U: Mandell GL, Bennett JE, Dolin R ur. Principles and practice of infectious diseases. Philadelphia: Churchill Livingstone; 2000, str. 1652-6.
8. Dienstag JL, Isselbacher KJ. Akutni hepatitis. U: Iselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL. Harrison Principi interne medicine. Split: Placebo; 1997, str. 1275-91.
9. Groshiede P, Van Damme P. Prevention and control of hepatitis B in the community. Viral Hepatitis Prevention Board. Communicable Diseases Series. Antwerpen 1996:3-50.
10. Bradarić N. Osobno priopćenje, ožujak 2005.
11. World Health Organization. Hepatitis B, 2002; http://www.who.int/csr/ disease/hepatitis.
12. Palmović D. Liječenje i prevencija virusnog hepatitisa. Liječ Vjesn 2004;126:254-60.
13. Baklan Z, Gorisek JR, Poljak M, Pisec A. Prevalence of HIV, hepatitis B, C and G virus infections among injecting drug users on methadone maintenance treatment in Maribor. Wien Klin Wochenchr 2004;116 (Suppl 2):5-7.
14. Altice FL, Bruce RD, Walton MR, Buitrago MI. Adherence to hepatitis B virus vaccination at syringe exchange sites. J Urban Health 2005; 82(1):151-61.
15. Torbenson M, Kannangai R, Astemborski J i sur. High prevalence of occult hepatitis B in Baltimore injection drug users. Hepatology 2004; 39:51-7.
16. Hrvatski zdravstvenostatisticki ljetopis. Registar liječenih ovisnika o psihoaktivnim drogama u Hrvatskoj. Zagreb: Hrvatski zavod za javno zdravstvo; 2004, str. 333.
17. Zakon o zaštiti pučanstva od zaraznih bolesti. NN RH br. 60/92:1338-48.
18. Pravilnik o načinu provocrossed d signenja imunizacije, seroprofilakse i kemoprofilakse protiv zaraznih bolesti te o osobama koje se podvrgavaju toj obvezi. NN RH br. 23/94.
19. Pravilnik o načinu provocrossed d signenja imunizacije, seroprofilakse i kemoprofilakse protiv zaraznih bolesti te o osobama koje se podvrgavaju toj obvezi. NN RH br. 164/04.
20. Pravilnik o izmjenama i dopunama pravilnika o načinu provocrossed d signenja imunizacije, seroprofilakse i kemoprofilakse protiv zaraznih bolesti te o osobama koje se podvrgavaju toj obvezi. NN RH br. 62/99.
21. McMahon BJ, Alward WLM, Hall DB i sur. Acute hepatitis B infection: relation of age to the clinical expression of disease and subsequent development of carrrier state. J Infect Dis 1985;151:599-603.
22. Beasley RP, Stevens CE, Shiao IS, Meng HC. Evidence against breast-feeding as a mechanism for vertical transmission of hepatitis B. Lancet 1975;2:740-1.
23. Ivić I, Banović I, Bradarić N. Hepatitis B virus infection among pregnant women in Split region. Eur J Epidemiol 1999;15:589-90.
24. Provedbeni program obveznog cijepljenja u Hrvatskoj. Republika Hrvatska. Ministarstvo zdravstva. Zagreb, 1999.
25. Choundury RP, Cleator SJ. An examination of needlestick onjury rates, hepatitis B vaccination uptake and instruction on sharps technique among medical students, J Hospit Infec 1992;22:143-8.
26. Buti M, Viladomiu L, Jardi R i sur. Long-term immunogenicity and efficacy of hepatitis B vaccine in hemodyalisis patients. Am J Nephrol 1992;12:144-7.
27. Friedland GH, Selwyn PA. Infekcije (izuzev AIDS) u intravenskih ovisnika. U: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, ur. Harrison Principi interne medicine. Split: Placebo; 1997, str. 495-9.
28. Grgičević D, Balija M, Pirc-Tiljak D i sur. Decreasing risk of viral transfusion-transmitted diseases in Croatia. Croat Med J 2000;41(2): 191-6.
29. Rich JD, McKenzie M, Macalino GE i sur. A syringe prescription program to prevent infectious disease and improve health of injection drug users. J Urban Health 2004;81(1):122-34.
30. crossed D signaković-Rode O, Palmović D, Kosanović I. Zaštita djelatnika kliničke bolnice »Sestre milosrdnice« od infekcije virusom hepatitisa B. Liječ Vjes 1997;119:226-30.
31. Ropac D, Zorić I, Palmović D i sur. The prevalence of hepatitis B virus infection among medical workers prior to vaccination. Period Biol 2001;103(1):45-8.
32. Palmović D, Palmović-Crnjaković J. Vaccination against hepatitis B. results of the analysis of 2000 population members in Croatia. Eur J Epidemiol 1999;15:541-7.
33. Mulić R, Ropac D. Procijepljenost zdravstvenih djelatnika protiv hepatitisa B u Hrvatskoj: razlozi necijepljenja. Med Jad 2001;31:63-70.
34. Lee DJ, Carillo L, Fleming L. Epidemiology of hepatitis vaccine acceptance among urban paramedics and emergency medical technicians. Am J Infect Control 1997;25:421-3.
35. Lunn JA. Hepatitis B vaccination. Br Med J 1993;307:732.
36. Ribera EF, Dutka AJ. Polyneuropathy associated with administration of hepatitis B vaccine. N Engl J Med 1983;309:614.
37. Carmeli Y, Oren R. Hepatitis B vaccine side-effect. Lancet 1993; 341:250-1.
38. Di Giusto CA, Bernhard JD. Erythema nodosum provoked by hepatitis B vaccine. Lancet 1986;2:1042.
39. Freid M, Conen D, Conzelmann M, Steinmann E. Uveitis after hepatitis B Vaccination. Lancet 1987;2:631-2.
40. Rogerson SJ, Nye FJ. Hepatitis B vaccine associated with erythema nodosum and polyarthritis. Br Med J 1990;301:345.
41. Multiple sclerosis and hepatitis B vaccine. Meeting report. Vaccine 1999;17:2473-5.
42. Stephenne J. Development and production aspects of recombinant yeast-derived hepatitis vaccine. Vaccine 1990;8:69-73.